期刊文献+

P53-mdm2相互作用与肿瘤治疗策略 被引量:2

P53-mdm2 Reciprocity and Cancer Cherapy
下载PDF
导出
摘要 mdm2是P53肿瘤抑制功能的主要调节者,两者之间存在自动调节的负反馈环,mdm2可通过与P53结合促进其降解。由诸多因素造成的mdm2-p53相互关系失衡所带来的直接后果就是导致p53的失活而引起肿瘤的发生。已证明有3种翻译后修饰:磷酸化、寡聚化及与其它蛋白的结合影响着mdm2、P53蛋白复合物的形成。干扰两者的结合,使P53发挥转录活性是抗肿瘤的关键。mdm2和P53蛋白相互作用抑制剂的研究是抗肿瘤治疗的一个新靶点,有广阔的应用前景。
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2005年第4期303-305,共3页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金(30471942) 陕西省科技攻关项目(2004k11-G3)
关键词 P53 MDM2 肿瘤治疗
  • 相关文献

参考文献18

  • 1Lahav G, Rosenfeld N, Sigal A, et al. Dynamics of the p53-mdm2 feedback loop in individuall cells[ J ]. Nat Genet, 2004, 36 (2) :147-150. 被引量:1
  • 2Ryan KM, Phillips AC, Vousden KH. Regulation and function of the p53 tumor suppressor protein[J]. Curt Opin Cell Biol, 2001,13 (3) : 332-337. 被引量:1
  • 3Ashcroft M, Taya Y, Vousden KH. Stress signals utilize multiple pathways to stabilize p53 [ J ]. Mol Cell Biol, 2000, 20(9) : 3224-3233. 被引量:1
  • 4Kussie PH, Gorina S, Marechal V, et al. Structure of the mdm2oncoprotein bound to p53 tumour suppressor transactivation domain [J]. Science, 1996, 274(5289) : 948-953. 被引量:1
  • 5Vousden KH. Activation of p53 tumor suppressor protein[ J ]. Biochim Biophys Acta, 2002, 1602( 1 ) : 47-59. 被引量:1
  • 6Brooks CL, Gu W. Ubiquitination, phosphorylation and acctylation: the molecular basis for p53 regulation [ J ]. Curt Opin Cell Biol, 2003, 15(2) : 164-171. 被引量:1
  • 7Brooks CL, Gu W. Dynamics in the p53-mdnd ubiquitination pathway[J]. Cell Cycle, 2004, 3(7) : 895-899. 被引量:1
  • 8Mayo LD, Donner DB. A phosphafidylinositol 3-kinase/Akt pathway promotes translocation of mdm2 from the cytoplasm to the nudells[ J ]. Proc Nail Acad Sci USA, 2001, 98 ( 20 ) : 11598-11603. 被引量:1
  • 9Ries S, Biederer C, Woods D, et al. Opposing effects of Ras on p53: Transcriptional activation of mdm2 and induction of p19(ARF) [J]. Cell, 2000, 103(2) : 321-330. 被引量:1
  • 10Chene P, Fuchs J, Bohn J, et al. A small synthetic peptide,which inhibits p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines[J]. J Mol Boil, 2000, 299(1 ): 245-253. 被引量:1

同被引文献30

  • 1史爱学,杨举伦.p53基因治疗恶性肿瘤的现状与趋势[J].西南国防医药,2004,14(1):101-104. 被引量:5
  • 2王朝霞,束永前.重组腺病毒p53基因治疗肺癌的研究进展[J].中国肺癌杂志,2005,8(2):148-151. 被引量:10
  • 3Zhi Guo,Hong Ni,Bin Li,Wenge Xing,Fang Liu,Haipeng Yu,Baoguo Li,Xiuying Guo.The Effect of the MDM2-p53 Loop on the Sensitivity of Ovarian Cancer Cells to Cisplatin[J].Chinese Journal of Clinical Oncology,2006,3(2):87-91. 被引量:2
  • 4Cahilly-Snyder L, Yang-Feng T, Francke U, et al. Molecular a- nalysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line [ J ]. Somat Cell Mol Genet, 1987, 13 (3): 235-244. 被引量:1
  • 5Liu G, Wheatley-Price P, Zhou W, et al. Genetic polymor- phisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk [J]. Int J Cancer, 2008, 122 (4): 915- 918. 被引量:1
  • 6Wang X, Zhang X, Qiu B, et al. MDM2 SNP309T > G polymor- phism increases susceptibility to hepatitis B virus-related hepatocel- lular carcinoma in a northeast Han Chinese population [ J ]. Liver Int, 2012, 32 (7): 1172-1178. 被引量:1
  • 7Song B, Duan ZY, Zhong YH, et al. Meta-ana!ysis of the MDM2 T309G polymorphism and gastric cancer risk [ J]. Asian Pac J Cancer Prev, 2013, 14 (11): 6649-6651. 被引量:1
  • 8Olsson H, Hultman P, Rosell J, et al. MDM2 SNP309 promot- er polymorphism and p53 mutations in urinary bladder carcinoma stageT1 [J]. BMC Uml, 2013, 13: 5. 被引量:1
  • 9Jiang T, Zhou C, Gu J, et al. Enhanced therapeutic effect of cisplatin on the prostate cancer in tumor-bearing mice by transfect- ing the attenuated Salmonella carrying a plasmid co-expressing p53 geneand mdm2 siRNA [J]. Cancer Lett, 2013, 337 (1): 133 - 142. 被引量:1
  • 10Tovar C, Higgins B, Kolinsky K, et al. MDM2 antagonists boost ntitumor effect of androgen withdrawal : implications for ther- apy of prostate cancer [J]. Mol Cancer, 2011, 10 (1) : 49. 被引量:1

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部